Page 49 - நாஸ்டாக் உலகளாவிய தேர்ந்தெடுக்கவும் சந்தை News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Royal Gold : Press Release dated July 13, 2021 (Form 8-K)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Why Slowing Deep Sea Mining Benefits All Involved
triplepundit.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from triplepundit.com Daily Mail and Mail on Sunday newspapers.
MIL-OSI: Paycor Announces Launch of Initial Public Offering
foreignaffairs.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foreignaffairs.co.nz Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
NEW YORK, July 9, 2021 /PRNewswire/ Pomerantz LLP announces that a class action lawsuit has been filed against Orphazyme A/S ( Orphazyme or the Company ) (NASDAQ: ORPH) and certain of its officers and directors. The class action, filed in the United States District Court for the Northern District of Illinois, Eastern Division, and docketed under 21-cv-03640, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired: (a) Orphazyme American depositary shares ( ADSs ) pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company s initial public offering conducted on or about September 29, 2020 (the IPO or Offering ); and/or (b) Orphazyme securities between September 29, 2020 and June 18, 2021, both dates inclusive (the Class Period ). Plaintiff pursues claims against the Defendants under the Securities Act of 1933 (the Securitie
NEW YORK, July 9, 2021 /PRNewswire/ Pomerantz LLP announces that a class action lawsuit has been filed against Orphazyme A/S (“Orphazyme” or the “Company”) (NASDAQ:ORPH) and certain of its officers and directors. The class action, filed in the United States District Court for the Northern District of Illinois, Eastern Division, and docketed under 21-cv-03640, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired: (a) Orphazyme American depositary shares (“ADSs”) pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company’s initial public offering conducted on or about September 29, 2020 (the “IPO” or “Offering”); and/or (b) Orphazyme securities between September 29, 2020 and June 18, 2021, both dates inclusive (the “Class Period”). Plaintiff pursues claims against the Defendants under the Securities Act of 1933 (the “Securities Act”) and